Red cell alloimmunization in multitransfused hepatobiliary patients at hospital Selayang

BACKGROUND: Transfusion support is vital for the management of patients with hepatobiliary disease. Repeated blood transfusions increase the risk of alloimmunization, i.e., the development of alloantibodies, which might lead to difficulties in blood crossmatching. AIMS: This study aims to: (1) deter...

Full description

Saved in:
Bibliographic Details
Main Authors: Prasanthini Nahendran, Siti Balkis Budin, Nur Zakiah Mohd Saat, Mohd Faeiz Yusop, Tengku Norita Tengku Yazid, Nur Najmi Mohamad Anuar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-12-01
Series:Asian Journal of Transfusion Science
Subjects:
Online Access:https://journals.lww.com/10.4103/ajts.ajts_75_22
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850114373962432512
author Prasanthini Nahendran
Siti Balkis Budin
Nur Zakiah Mohd Saat
Mohd Faeiz Yusop
Tengku Norita Tengku Yazid
Nur Najmi Mohamad Anuar
author_facet Prasanthini Nahendran
Siti Balkis Budin
Nur Zakiah Mohd Saat
Mohd Faeiz Yusop
Tengku Norita Tengku Yazid
Nur Najmi Mohamad Anuar
author_sort Prasanthini Nahendran
collection DOAJ
description BACKGROUND: Transfusion support is vital for the management of patients with hepatobiliary disease. Repeated blood transfusions increase the risk of alloimmunization, i.e., the development of alloantibodies, which might lead to difficulties in blood crossmatching. AIMS: This study aims to: (1) determine the incidence of red blood cell (RBC) alloimmunization and (2) evaluate the associations between antibody development and demographic factors among hepatobiliary patients. METHOD: ABO blood grouping, antibody screening, antibody identification and crossmatch were done on all patients samples included in the study. SETTINGS AND DESIGN: A cross-sectional study was conducted from February 2021 to September 2021, with a total of 132 samples from hepatobiliary patients. The relationships between RBC alloimmunization in transfused hepatobiliary patients and demographic factors (gender, age, and history of transfusion) were assessed by binary logistic regression. RESULTS: Overall, 67.4% of the patients developed alloimmunization. The majority had a single alloantibody (75.2%) and the most frequently identified antibody specificities were anti-E (37.6%), anti-c (12.8%), anti-Mia (14.4%), and anti-Kidd (11.2%). The predominant antibodies were those against the Rh system (58.4%). Female patients recorded the highest incidence of alloimmunization (69.8%). Female patients also demonstrated a higher tendency to produce both anti-E + anti-c than male patients. CONCLUSION: The prevalence of RBC alloimmunization is high among hepatobiliary patients and it may cause complications requiring multiple transfusions. The number of transfused packed cells has been clearly shown to be proportionally significant with the risk for alloimmunization in hepatobiliary patients. Hence, this study highlights the importance of immunohematology tests before blood transfusion.
format Article
id doaj-art-e012a65502ba48baa19581a48c0434b3
institution OA Journals
issn 0973-6247
1998-3565
language English
publishDate 2024-12-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Asian Journal of Transfusion Science
spelling doaj-art-e012a65502ba48baa19581a48c0434b32025-08-20T02:36:53ZengWolters Kluwer Medknow PublicationsAsian Journal of Transfusion Science0973-62471998-35652024-12-0118228629010.4103/ajts.ajts_75_22Red cell alloimmunization in multitransfused hepatobiliary patients at hospital SelayangPrasanthini NahendranSiti Balkis BudinNur Zakiah Mohd SaatMohd Faeiz YusopTengku Norita Tengku YazidNur Najmi Mohamad AnuarBACKGROUND: Transfusion support is vital for the management of patients with hepatobiliary disease. Repeated blood transfusions increase the risk of alloimmunization, i.e., the development of alloantibodies, which might lead to difficulties in blood crossmatching. AIMS: This study aims to: (1) determine the incidence of red blood cell (RBC) alloimmunization and (2) evaluate the associations between antibody development and demographic factors among hepatobiliary patients. METHOD: ABO blood grouping, antibody screening, antibody identification and crossmatch were done on all patients samples included in the study. SETTINGS AND DESIGN: A cross-sectional study was conducted from February 2021 to September 2021, with a total of 132 samples from hepatobiliary patients. The relationships between RBC alloimmunization in transfused hepatobiliary patients and demographic factors (gender, age, and history of transfusion) were assessed by binary logistic regression. RESULTS: Overall, 67.4% of the patients developed alloimmunization. The majority had a single alloantibody (75.2%) and the most frequently identified antibody specificities were anti-E (37.6%), anti-c (12.8%), anti-Mia (14.4%), and anti-Kidd (11.2%). The predominant antibodies were those against the Rh system (58.4%). Female patients recorded the highest incidence of alloimmunization (69.8%). Female patients also demonstrated a higher tendency to produce both anti-E + anti-c than male patients. CONCLUSION: The prevalence of RBC alloimmunization is high among hepatobiliary patients and it may cause complications requiring multiple transfusions. The number of transfused packed cells has been clearly shown to be proportionally significant with the risk for alloimmunization in hepatobiliary patients. Hence, this study highlights the importance of immunohematology tests before blood transfusion.https://journals.lww.com/10.4103/ajts.ajts_75_22alloantibodiesalloimmunizationclinically significanthepatobiliarytransfusion
spellingShingle Prasanthini Nahendran
Siti Balkis Budin
Nur Zakiah Mohd Saat
Mohd Faeiz Yusop
Tengku Norita Tengku Yazid
Nur Najmi Mohamad Anuar
Red cell alloimmunization in multitransfused hepatobiliary patients at hospital Selayang
Asian Journal of Transfusion Science
alloantibodies
alloimmunization
clinically significant
hepatobiliary
transfusion
title Red cell alloimmunization in multitransfused hepatobiliary patients at hospital Selayang
title_full Red cell alloimmunization in multitransfused hepatobiliary patients at hospital Selayang
title_fullStr Red cell alloimmunization in multitransfused hepatobiliary patients at hospital Selayang
title_full_unstemmed Red cell alloimmunization in multitransfused hepatobiliary patients at hospital Selayang
title_short Red cell alloimmunization in multitransfused hepatobiliary patients at hospital Selayang
title_sort red cell alloimmunization in multitransfused hepatobiliary patients at hospital selayang
topic alloantibodies
alloimmunization
clinically significant
hepatobiliary
transfusion
url https://journals.lww.com/10.4103/ajts.ajts_75_22
work_keys_str_mv AT prasanthininahendran redcellalloimmunizationinmultitransfusedhepatobiliarypatientsathospitalselayang
AT sitibalkisbudin redcellalloimmunizationinmultitransfusedhepatobiliarypatientsathospitalselayang
AT nurzakiahmohdsaat redcellalloimmunizationinmultitransfusedhepatobiliarypatientsathospitalselayang
AT mohdfaeizyusop redcellalloimmunizationinmultitransfusedhepatobiliarypatientsathospitalselayang
AT tengkunoritatengkuyazid redcellalloimmunizationinmultitransfusedhepatobiliarypatientsathospitalselayang
AT nurnajmimohamadanuar redcellalloimmunizationinmultitransfusedhepatobiliarypatientsathospitalselayang